Kleinschnitz C - Search Results

1

Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab.

Pfeuffer S, Rolfes L, Ingwersen J, Pul R, Kleinschnitz K, Korsen M, Räuber S, Ruck T, Schieferdecker S, Willison AG, Aktas O, Kleinschnitz C, Hartung HP, Kappos L, Meuth SG. Pfeuffer S, et al. Among authors: kleinschnitz k, kleinschnitz c. Neurol Neuroimmunol Neuroinflamm. 2023 Apr 11;10(3):e200104. doi: 10.1212/NXI.0000000000200104. Print 2023 May. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37041077 Free PMC article.

2

T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression.

Kleinschnitz C, Hofstetter HH, Meuth SG, Braeuninger S, Sommer C, Stoll G. Kleinschnitz C, et al. Exp Neurol. 2006 Aug;200(2):480-5. doi: 10.1016/j.expneurol.2006.03.014. Epub 2006 May 3. Exp Neurol. 2006. PMID: 16674943

3

Immunotherapeutic approaches in MS: update on pathophysiology and emerging agents or strategies 2006.

Kleinschnitz C, Meuth SG, Kieseier BC, Wiendl H. Kleinschnitz C, et al. Endocr Metab Immune Disord Drug Targets. 2007 Mar;7(1):35-63. doi: 10.2174/187153007780059414. Endocr Metab Immune Disord Drug Targets. 2007. PMID: 17346203 Review.

4

[Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].

Kleinschnitz C, Meuth SG, Kieseier BC, Wiendl H. Kleinschnitz C, et al. Nervenarzt. 2007 Aug;78(8):883-911. doi: 10.1007/s00115-007-2261-9. Nervenarzt. 2007. PMID: 17551708 Review. German.

5

Multiple sclerosis therapy: an update on recently finished trials.

Kleinschnitz C, Meuth SG, Stüve O, Kieseier B, Wiendl H. Kleinschnitz C, et al. J Neurol. 2007 Nov;254(11):1473-90. doi: 10.1007/s00415-007-0684-7. Epub 2007 Nov 15. J Neurol. 2007. PMID: 18004638 Review.

6

The trials and errors in MS therapy.

Kleinschnitz C, Meuth SG, Wiendl H. Kleinschnitz C, et al. Int MS J. 2008 Sep;15(3):79-90. Int MS J. 2008. PMID: 18808741 Review.

7

Transient widespread blood-brain barrier alterations after cerebral photothrombosis as revealed by gadofluorine M-enhanced magnetic resonance imaging.

Stoll G, Kleinschnitz C, Meuth SG, Braeuninger S, Ip CW, Wessig C, Nölte I, Bendszus M. Stoll G, et al. Among authors: kleinschnitz c. J Cereb Blood Flow Metab. 2009 Feb;29(2):331-41. doi: 10.1038/jcbfm.2008.129. Epub 2008 Oct 29. J Cereb Blood Flow Metab. 2009. PMID: 18957988

8

Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

Multiple Sclerosis Therapy Consensus Group (MSTCG); Wiendl H, Toyka KV, Rieckmann P, Gold R, Hartung HP, Hohlfeld R. Multiple Sclerosis Therapy Consensus Group (MSTCG), et al. J Neurol. 2008 Oct;255(10):1449-63. doi: 10.1007/s00415-008-0061-1. Epub 2008 Oct 29. J Neurol. 2008. PMID: 19005625

9

[Multiple sclerosis -- a channelopathy? Targeting ion channels and transporters in inflammatory neurodegeneration].

Meuth SG, Melzer N, Kleinschnitz C, Budde T, Wiendl H. Meuth SG, et al. Among authors: kleinschnitz c. Nervenarzt. 2009 Apr;80(4):422-9. doi: 10.1007/s00115-008-2599-7. Nervenarzt. 2009. PMID: 19011824 Review. German.

10

Recent clinical trials and future therapies.

Meuth SG, Kleinschnitz C, Wiendl H. Meuth SG, et al. Among authors: kleinschnitz c. J Neurol. 2008 Dec;255 Suppl 6:93-6. doi: 10.1007/s00415-008-6017-7. J Neurol. 2008. PMID: 19300967 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

489 results

Search Page